Rachel Tackley awarded MBE for services to the arts
Rachel Tackley, Creative Director and Co-Chief Executive of The Arts Theatre Cambridge, has been awarded an MBE in the King’s New Year Honours List in recognition of her outstanding services to the arts.
Greater Cambridge bucks national trend as it closes gap between housing consents and builds
There is a significant national lag between the number of homes getting planning approval and the number of homes being built – but the Greater Cambridge area (Cambridge and South Cambridgeshire) is bucking the trend.
Tell stories
Stories give ideas a pulse; they allow the audience to really feel something.
UK startups face a funding squeeze but EpiCentre founders are pivoting, not pausing
Across the UK, founders are feeling the squeeze. Investors are cautious, politics is volatile and the days of easy capital are firmly behind us. Yet at The EpiCentre in Haverhill, a different story is unfolding, defined not by paralysis but by creativity and persistence. During a recent podcast recording at the centre, founders and experts reflected on what many describe as the toughest…
Enhanced Genomics appoints Dr Katerina Leftheris to its Board of Directors
Experienced leader in preclinical and clinical drug development will support expansion of Company’s therapeutics pipeline for complex and common genetic diseases
Winter events with Cambridge Dining Co.
This last season has been an exceptionally busy and rewarding one for Cambridge Dining Co., delivering a wide range of corporate festive events across Cambridgeshire.
Commemorative service honours Katherine of Aragon at Kimbolton School
On the anniversary of Katherine of Aragon’s death, a special commemorative service was held in the Kimbolton School Chapel on 7 January at 3:00pm to honour her life as the first wife of Henry VIII and one of the most compelling figures of the Tudor period. The service marked almost 500 years since her death.
Why 454 million people are waiting for a device already in their pocket
The Smartphone Revolution in Respiratory Care Has Arrived, And It Changes Everything
Bidwells completes merger with Creative Places to strengthen Science & Technology offer
Bidwells has completed the merger of Creative Places LLP into the firm, strengthening its Science & Technology capability and further enhancing its expertise in R&D and innovation-led real estate.
FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference
PORTO, Portugal, 08 January, 2026 – FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer, Dr. Werner Lanthaler, will present at the J.P.
Redgate Software announces strategic growth investment from Bregal Sagemount for next phase of growth and portfolio expansion
Redgate Software, the trusted Database DevOps solution provider, announces a strategic growth investment from Bregal Sagemount (“Sagemount”), a leading growth-focused private equity firm. Terms of the transaction were not disclosed.
Prior Scientific launches PureFocus690: Advanced hardware laser autofocus for Raman and Infrared Microscopy
Prior Scientific, a global leader in precision optical instrumentation, has enhanced its advanced hardware autofocus range with the addition of the PureFocus690, designed for Raman and infrared microscopy applications.
More on essential hybrid DAS
Are private wireless networks enough to meet everyday connectivity needs inside your facility?
Many enterprises are finding they’re not.
From speed to proof: what happens when innovation meets system maturity
For many founders, the early phase of innovation is familiar territory. A strong idea gains traction, early pilots show promise, and momentum builds around speed — speed to prototype, speed to market, speed to scale.
Nuclera eProtein Discovery System installed at leading Universities in Taiwan
Installations at National Taiwan University and National Cheng Kung University expand Nuclera’s global footprint with first commercial sales in AsiaSystem strengthens Taiwan’s capabilities in protein drug discovery researchCambridge, UK, and Bo
Qureight appoints Dr Steven Bishop as Chief Medical Officer
Change in role from Chief Data Officer reflects Qureight’s continued growth and commercial success in delivering customers’ clinical studies
Why gene therapy matters now
This month, VacZine Analytics, a specialist publisher in healthcare commercial analysis, releases a brand-new situation review on the FDA approved "classical" gene therapy landscape.
AI in marketing: separating hype from useful
Beth's latest piece at KISS cuts through the noise around "AI imposter syndrome," addressing that nagging feeling that everyone else has AI figured out while you're still working out which tool does what.
New year - same you?
When you think of new year resolutions, are you also seeking to create a new you? STOP What if the New You isn't needed? What if the same you is truly good enough? You just don't believe it yet...
Royal College Fellowship joy for three CPFT psychiatrists
Three psychiatrists at Cambridgeshire and Peterborough NHS Foundation Trust (CPFT) have been awarded prestigious Fellowships by the Royal College of Psychiatrists, honouring their outstanding contributions to mental health care and research.
University announces new partnership with AstraZeneca and Beijing municipal parties to accelerate innovations in healthcare
The University of Cambridge, AstraZeneca and Beijing municipal parties (the Beijing Science and Technology Commission and the Beijing Economic and Technological Development Area), have signed an agreement that will enhance collaboration between the University, AstraZeneca and Cambridge and Beijing’s life sciences ecosystems.
42 Technology and Innatera partner to advance neuromorphic Edge AI
42 Technology is partnering with Innatera, a leader in brain-inspired Edge AI processors, to help its clients access the latest breakthroughs in ultra-low power intelligence at the sensor edge for new product innovations.
Share your views - The Institute for Biomedical Innovation (IBI)
The Institute for Biomedical Innovation (IBI) is a new major investment by the University of Cambridge. Based in the Department of Engineering, the IBI aims to turn early-stage medical technologies into safe, sustainable, clinically ready devices.
UK CFOs upbeat on tech investment and potential for AI to boost productivity for year ahead
More than half of finance chiefs (59%) have become more optimistic over the past 12 months on the potential for AI to boost the performance of their organisation, up from 39% in Q3 of 2024; Almost all of them (96%) expect to see a rise in investment in digital technology and assets by UK companies in the next five years; Corporate risk appetite (15%) has edged up from the lows seen in…
Legacies of Windrush in Cambridge
Last few weeks to see The Museum of Cambridge exhibition, shining a light on the lives and experiences of the Caribbean Windrush community and those who left an indelible mark on Cambridge and the UK.